Composition, form of production and packaging
? Gel for external use 5% transparent, colorless, with a characteristic odor.
1 g
ibuprofen 50 mg
Excipients: isopropyl alcohol, 2,2-dimethyl-4-hydroxymethyl-1,3-dioxolane (solketal), poloxamer, triglycerides medium-chain (Miglyol 812), purified water, lavender oil, nerol (citrus) oil.
20 g - aluminum tubes (1) - packs of cardboard.
50 g - aluminum tubes (1) - packs of cardboard.
100 g - aluminum tubes (1) - packs of cardboard.
? Cream for external use 5% 1 g
ibuprofen 50 mg
Excipients: triglycerides, glycerol (glycerin), propylene glycol, sodium methyl-4-hydroxybenzoate, gum, xanthant, lavender oil, nerol oil, water.
20 g - aluminum tubes (1) - packs of cardboard.
50 g - aluminum tubes (1) - packs of cardboard.
100 g - aluminum tubes (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
PHARMACHOLOGIC EFFECT
NSAIDs for external use.
Dolgit has a local anti-inflammatory, analgesic and anti-exsudative action. The key link in the specific action of ibuprofen is the inhibition of the biosynthesis of prostaglandins, mediators of inflammation. It causes a weakening or disappearance of the pain syndrome (including joint pain at rest and during movement), a decrease in morning stiffness and swelling of the joints. Promotes an increase in the volume of movements.
PHARMACOKINETICS
The drug is used only for topical application: the concentration in the synovial fluid is 1.45 Ојg / ml. It is excreted mainly with urine.
INDICATIONS
Inflammatory and degenerative diseases of the musculoskeletal system:
- arthritis (rheumatoid, psoriatic);
- articular syndrome with rheumatism and exacerbation of gout;
- humeroscapular periarthritis;
- Bechterew's disease (ankylosing spondylitis);
- deforming osteoarthritis;
osteochondrosis with radicular syndrome;
- radiculitis;
- sciatica;
- Lumbago;
- Tendivitis, tendovaginitis, bursitis.
Myalgia (rheumatic and non-rheumatic origin).
Injuries (sports, industrial, household) without compromising the integrity of soft tissues:
- dislocations;
- stretching;
- ruptures of muscles or ligaments;
- bruises;
- Posttraumatic swelling of soft tissues.
DOSING MODE
The drug should be applied externally.
A strip of gel 5-10 cm long is applied to the skin in the area of ​​the painful area and carefully rubbed with light movements until the drug is completely absorbed 3-4 times / day. The gel should not be used under cover, airtight bandages. In severe cases, it is recommended to combine local therapy with oral administration of NSAIDs.
A strip of cream 5-10 cm long is applied to the skin in the area of ​​the painful area and carefully rubbed with light movements until the drug is completely absorbed 2-3 times / day. The course of treatment should not exceed 10 days without consulting a doctor.
The duration of therapy with Dolgit depends on the severity of the disease and the nature of the damage.
SIDE EFFECT
Allergic reactions: possible - bronchospasm (with increased sensitivity to NSAIDs); rarely - skin hyperemia, rash, swelling, burning sensation, tingling or itching of the skin.
If side effects or other unusual reactions occur, treatment with the drug should be discontinued, the possibility of further use of the drug is determined by the doctor.
CONTRAINDICATIONS
- wet dermatoses (for gel);
- eczema (for the gel);
- infected wounds and abrasions (for the gel);
- Children's age up to 1 year (for gel);
- Pregnancy;
- the period of breastfeeding;
- the presence in an anamnesis of attacks of bronchial asthma or other allergic manifestations associated with the use of acetylsalicylic acid and other NSAIDs;
- hypersensitivity to ibuprofen and other components of the drug.
PREGNANCY AND LACTATION
Contraindicated use of the drug during pregnancy and during breastfeeding.
SPECIAL INSTRUCTIONS
The drug should not be applied to the open wound surface, damaged skin or mucous membranes (avoid contact with the eyes).
If the therapy is ineffective, you should consult your doctor.
In severe cases it is recommended to combine local therapy with the intake of NSAIDs inside.
Use in Pediatrics
Dolgit in the form of a cream should not be used in children under the age of 12 without consulting a doctor.
Dolgit in the form of a gel can be used in children over the age of 1 year.
Impact on the ability to drive vehicles and manage mechanisms
The use of Dolgit cream does not affect activities requiring increased attention, coordination of movements, high speed of mental and physical reactions (including drivers of transport, persons servicing cars).
OVERDOSE
Symptoms: when using large amounts of gel on a large surface of the skin or getting into the mouth, abdominal pain, nausea, vomiting, drowsiness, headache may occur.
Treatment: remove residual gel from the surface of the skin or from the oral cavity. When large amounts of the drug enter the oral cavity, gastric lavage, the use of salt laxatives and symptomatic therapy are indicated.
Cases of an overdosage with Dolgit cream are not described.
Symptoms: with accidental ingestion of the drug, nausea and vomiting may occur.
Treatment: should clean the stomach (induce vomiting, take activated charcoal) and consult a doctor. Further treatment, if necessary, symptomatic.
DRUG INTERACTION
You should consult your doctor before using Dolgit cream if other medicines are used.
With external application of ibuprofen, no interactions with other drugs have been identified.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children, dry place at a temperature of 15 В° to 25 В° C. Shelf life - 3 years.
